Navigation Links
deCODE genetics Announces First Quarter 2008 Financial Results
Date:5/1/2008

except per share amounts

(unaudited)

Revenue $14,978 $8,554

OPERATING EXPENSES

Cost of revenue 14,714 10,918

Research and development 12,653 12,676

Selling, general and administrative 7,211 5,530

Total operating expense 34,578 29,124

Operating loss (19,600) (20,570)

Interest income 1,037 1,991

Interest expense (4,025) (3,666)

Other non-operating income and (expense), net* (4,077) (380)

Net loss $(26,665) $(22,625)

Basic and diluted net loss per share: $(0.44) $(0.37)

Shares used in computing basic and

diluted net loss per share 61,266 60,949

Condensed Consolidated Balance Sheet Data

At March 31, At December 31,

2008 2007

In thousands,

(unaudited)

Cash and investments ** $69,490 $94,058

Total assets 134,055 156,208

Total liabilities 303,520 301,858

Total shareholders' equity (deficit) (169,465) (145,650)

* Other non-operating expense for the three months ended March 31, 2008

principally reflects an unrealized loss resulting from the revaluation

of the company's non-current auction r
'/>"/>

SOURCE deCODE genetics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. deCODE Discovers Fourth Major Set of Common Genetic Variants Linked to Risk of Estrogen Receptor-Positive Breast Cancer
2. deCODE Lauds Federal Legislation to Ban Discrimination on the Basis of Genetic Information
3. deCODE genetics Announces Webcast of Conference Call to Discuss First Quarter 2008 Financial Results
4. U.S. Preventive Medicine and deCODE Genetics Sign Letter of Intent to Expand Personalized Medicine Platform
5. A Smoking Gene: deCODE Shows How a Single Variant in the Sequence of the Genome Confers Nicotine Dependence and Risk of Lung Cancer and Other Disease
6. deCODE genetics to Webcast Presentation at 15th Annual Future Leaders in the Biotech Industry Conference
7. deCODE genetics to Webcast Presentation at Lehman Brothers Eleventh Annual Global Healthcare Conference
8. deCODE Genetics Announces Full-year 2007 Financial Results
9. deCODE genetics Announces Webcast of Conference Call to Discuss Full-year 2007 Financial Results
10. deCODE genetics to Webcast Presentation at BIO CEO and Investor Conference
11. deCODE Discovers Gene Variants that May Help to Distribute the Work of Evolution between Men and Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
(Date:12/17/2014)... SOUTH SAN FRANCISCO, Calif. , Dec. 17, ... positive results of a Phase 2 study evaluating ... for the treatment of patients with severe, chronic ... the current standard of care, including topical steroids ... endpoint was percent change in Visual Analog Scale ...
(Date:12/15/2014)...  GlassesOff Inc. (OTCBB: GLSO) announced today the appointment ... director of the Company,s Board of Directors. ... its CEO until its acquisition by Stanley Black ... Recognized as the inventor of the first Wi-Fi-based Active ... -based RFID solutions focused on improving operational efficiency, safety ...
(Date:12/13/2014)... (PRWEB) December 12, 2014 Clarassance, a ... announced its new name: Therabron Therapeutics , Inc. ... and bronchioles (a type of structure in the lungs ... company’s mission to develop novel protein therapeutics for the ... directors decided to change the name to mark the ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2
... St. Network,s 3-Minute,Press Show is a daily program hosted ... public company executives on their,company and most recent press ... with insight into a company,s,latest news, and its impact ... air Monday through Friday at: http://tv.wallst.net/3-min-press/3-min-press.php , ...
... announced today that it will present at the Rodman ... 2008 at the New York,Palace Hotel in New York ... Jiwani, Vice President and Chief Financial Officer will,discuss the ... Eastern Time., Attendance at the conference is by ...
... Nov. 4 ADVENTRX Pharmaceuticals,Inc. (Amex: ANX ) ... ADVENTRX, is scheduled to present at the Rodman & ... to present,on Tuesday, November 11th, 2008 at 2:50 p.m. ... November 10-12, 2008 at the,Palace Hotel in New York., ...
Cached Biology Technology:[video] Wall St. Network's 3-Minute Press Show Features Executive Interviews and Highlights Recent Press for the Following: GTHR, BHRT, AGO 2Uroplasty to Present at the Rodman & Renshaw 10th Annual Healthcare Conference in New York 2
(Date:12/10/2014)...  Valencell, a leader in performance biometric data sensor ... from its licensees for highly accurate, clinically validated biometric ... coming from fitness and health sectors, but first responders/military ... is only as useful as the biometric data it ... in long-term mass consumer adoption of wearable products," said ...
(Date:12/10/2014)... SAN DIEGO , Dec. 9, 2014 ... and collaboration catalyst that provides the connective tissue that ... by enabling them to easily share client-level information; earned ... Foundation to expand to organizations serving seniors aging in ... San Diego" partner on December 11 th 4-6p. ...
(Date:12/10/2014)... 9, 2014     ...   Jifflenow, a ... solutions for business-to-business (B2B) events, today announced a ... mobile near-field communication (NFC), Bluetooth low energy (BLE), ... http://photos.prnewswire.com/prnh/20140612/691055) , Jifflenow will integrate its ...
Breaking Biology News(10 mins):Wearable Technology Products Demand Highly Accurate Biometric Technology 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3
... used to make cordite, the explosive propellant that replaced ... important new use in the production of advanced biofuels. ... the U.S. Department of Energy (DOE),s Lawrence Berkeley National ... acetone, butanol and ethanol from lignocellulosic biomass could be ...
... Deep in the inner ear of mammals is a natural ... electrical potential to drive neural signals. In today,s issue of ... from MIT, the Massachusetts Eye and Ear Infirmary (MEEI) and ... for the first time that this battery could power implantable ...
... Canadian and Italian stem cell researchers have discovered a new ... that manipulating its levels could potentially create a way ... published today online ahead of print in Cell Stem Cell, ... blood stem cells, says co-principal investigator Dr. John Dick, who ...
Cached Biology News:More bang for the biofuel buck 2More bang for the biofuel buck 3More bang for the biofuel buck 4Medical devices powered by the ear itself 2Medical devices powered by the ear itself 3Stem cell scientists discover potential way to expand cells for use with patients 2
... system, 220-240 V, is used for nucleic acid ... slab gel format. The system includes the modular ... separating nucleic acids with single base-pair resolution and ... and bonded inner glass plate, outer glass plate, ...
... PowerPac HV high-voltage power supply, with temperature probe, ... of 5,000 V, 500 mA, and 400 W. ... temperature between 0 and 90 degrees C during ... transfer. Power cord and instructions are provided. Dimensions ...
... cooling coil, Trans-Blot cell, provides ... high-intensity, and extended electrophoretic transfer ... Trans-Blot cell. Use of the ... to an external water recirculator, ...
... By incorporating a wide range of next-generation ... sets a new standard for flexible laboratory ... handling including pipetting, dilution, dispensing, and ... thats as powerful and flexible as it ...
Biology Products: